Irhythm Holdings, Inc. (IRTC) Stock Price & Analysis
Irhythm Holdings, Inc. (IRTC) rose 1.42% to USD 109.2 as of July 25, 2026 at 09:06 UTC, according to Nexqual real-time market data.
IRTC last closed at USD 107.67; the session ranged USD 106.39–109.84 on volume of 304,767 shares. Market capitalization is $3.59B, with a 52-week range of USD 100.85–212 (NMS). Source: Nexqual, July 25, 2026 at 09:06 UTC.
Key Statistics (as of July 25, 2026 at 09:06 UTC)
| Price | USD 109.2 |
|---|---|
| Change | ▲ 1.42% (up) |
| Previous Close | USD 107.67 |
| Open | USD 109.52 |
| Day Range | USD 106.39 – 109.84 |
| 52-Week Range | USD 100.85 – 212 |
| Volume | 304,767 shares |
| Market Cap | $3.59B |
| Exchange | NMS |
Technical Analysis (IRTC)
Nexqual's technical model rates IRTC "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 09:06 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 44.18 (neutral) |
| vs SMA50 | Below (USD 113.49) |
| MACD | -1.82 (negative) |
Analyst Ratings (IRTC)
Wall Street analysts rate IRTC "Strong Buy" based on 14 analysts, with a mean price target of USD 177.07 (range USD 150–255), per Nexqual as of July 25, 2026 at 09:06 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 14 |
| Mean Target | USD 177.07 |
| High Target | USD 255 |
| Low Target | USD 150 |
| Buy / Hold / Sell | 15 / 0 / 0 |
Earnings (IRTC)
| Next Earnings Date | 2026-08-06 |
|---|---|
| EPS Estimate | USD -0 |
| Revenue Estimate | $219.33M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.35 vs est -0.64 ▲ beat |
| 2025-12-31 | USD 0.29 vs est 0.06 ▲ beat |
| 2025-09-30 | USD -0.06 vs est -0.28 ▲ beat |
| 2025-06-30 | USD -0.32 vs est -0.47 ▲ beat |
Source: Nexqual, July 25, 2026 at 09:06 UTC.
Financials & Fundamentals (IRTC)
| Total Revenue | $787.85M |
|---|---|
| Revenue Growth (YoY) | +25.70% |
| Gross Margin | +71.00% |
| Operating Margin | -5.95% |
| Profit Margin | -3.53% |
| ROE | -22.42% |
| Debt / Equity | 452.39 |
| Current Ratio | 5.17 |
| Total Cash | $549.62M |
| Total Debt | $729.29M |
| Free Cash Flow | $57.02M |
Source: Nexqual, July 25, 2026 at 09:06 UTC.
Financial Health Score (IRTC)
Nexqual rates Irhythm Holdings, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 09:06 UTC.
| Growth | Strong — Revenue +26% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 71%, operating -6% |
| Balance Sheet | Weak — $550M cash vs $729M debt |
| Cash Flow | Solid — FCF $57M, 8% margin |
| Efficiency | Critical — ROE -22%, ROA -1.1% |
Ownership (IRTC)
| Insider Ownership | +1.16% |
|---|---|
| Institutional Ownership | +110.21% |
| Shares Outstanding | 32.86M |
| Float | 30.79M |
| Short % of Float | +10.54% |
Source: Nexqual, July 25, 2026 at 09:06 UTC.
Leadership (IRTC)
Irhythm Holdings, Inc. is led by Quentin S. Blackford (age 46), President, CEO & Director, per Nexqual as of July 25, 2026 at 09:06 UTC.
| President, CEO & Director | Quentin S. Blackford (age 46) |
|---|---|
| CFO & Principal Financial Officer | Daniel G. Wilson (age 43) |
| Executive Vice President of Business Operations | Mervin Smith (age 50) |
| Executive VP & CTO | Brian Lawrence (age 55) |
| Senior Vice President of Finance & Investor Relations | Lisa Pecora |
Major Backers & Investors (IRTC)
Notable institutional backers of Irhythm Holdings, Inc. include RTW Investments LP, Millennium Management, Artisan Partners Limited Partnership, according to Nexqual as of July 25, 2026 at 09:06 UTC.
Active Investors
| Investor | Stake |
|---|---|
| RTW Investments LP | 5.08% |
| Millennium Management | 4.89% |
| Artisan Partners Limited Partnership | 4.42% |
| FMR, LLC | 4.14% |
| Holocene Advisors, LP | 3.8% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3.19% |
| SmallCap World Fund Inc | 1.41% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 19.02% |
| BlackRock | 10.66% |
| Geode Capital | 2.49% |
Source: Nexqual, July 25, 2026 at 09:06 UTC.
From Irhythm Holdings, Inc.'s Latest SEC 10-K Filing (filed 2026-02-19)
Key Strengths & Strategy (as disclosed to the SEC)
- iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States.
- The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.
- It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data.
- In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PEN | Penumbra, Inc. | USD 318.73 | ▲ 0.7% |
| GKOS | Glaukos Corporation | USD 153.58 | ▲ 0.47% |
| PODD | Insulet Corporation | USD 163.26 | ▲ 2.72% |
| LIVN | LivaNova PLC | USD 78.19 | ▼ 0.1% |
| NTRA | Natera, Inc. | USD 261.99 | ▼ 0.84% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 09:06 UTC. This page is informational and not investment advice.